DE3782840D1 - Arzneimittel mit verzoegerter freigabe. - Google Patents

Arzneimittel mit verzoegerter freigabe.

Info

Publication number
DE3782840D1
DE3782840D1 DE8787302518T DE3782840T DE3782840D1 DE 3782840 D1 DE3782840 D1 DE 3782840D1 DE 8787302518 T DE8787302518 T DE 8787302518T DE 3782840 T DE3782840 T DE 3782840T DE 3782840 D1 DE3782840 D1 DE 3782840D1
Authority
DE
Germany
Prior art keywords
delayed release
medicinal products
medicinal
products
delayed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787302518T
Other languages
English (en)
Other versions
DE3782840T2 (de
Inventor
Brent D Massmann
Herman J Eichel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kinaform Technology Inc
Original Assignee
Kinaform Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kinaform Technology Inc filed Critical Kinaform Technology Inc
Publication of DE3782840D1 publication Critical patent/DE3782840D1/de
Application granted granted Critical
Publication of DE3782840T2 publication Critical patent/DE3782840T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8787302518T 1986-03-27 1987-03-24 Arzneimittel mit verzoegerter freigabe. Expired - Fee Related DE3782840T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84467686A 1986-03-27 1986-03-27
US1798887A 1987-02-24 1987-02-24

Publications (2)

Publication Number Publication Date
DE3782840D1 true DE3782840D1 (de) 1993-01-14
DE3782840T2 DE3782840T2 (de) 1993-04-01

Family

ID=26690594

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787302518T Expired - Fee Related DE3782840T2 (de) 1986-03-27 1987-03-24 Arzneimittel mit verzoegerter freigabe.

Country Status (7)

Country Link
EP (1) EP0239361B1 (de)
JP (2) JP2657057B2 (de)
AU (1) AU591248B2 (de)
CA (1) CA1285482C (de)
DE (1) DE3782840T2 (de)
DK (1) DK153787A (de)
NO (1) NO175286C (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE460945B (sv) * 1987-01-15 1989-12-11 Lejus Medical Ab En multipel-unit-dos komposition av furosemid
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
US5026559A (en) * 1989-04-03 1991-06-25 Kinaform Technology, Inc. Sustained-release pharmaceutical preparation
AU632602B2 (en) * 1989-08-02 1993-01-07 John David Arnold Method and preparation for reducing risk of myocardial infarction
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
US5571533A (en) * 1992-02-07 1996-11-05 Recordati, S.A., Chemical And Pharmaceutical Company Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
WO1994003160A1 (en) * 1992-08-05 1994-02-17 F.H. Faulding & Co. Limited Pelletised pharmaceutical composition
AU670958B2 (en) * 1992-08-05 1996-08-08 Mayne Pharma International Pty Ltd Pelletised pharmaceutical composition
ES2068762B1 (es) * 1993-07-21 1995-12-01 Lipotec Sa Un nuevo preparado farmaceutico para mejorar la biodisponibilidad de drogas de dificil absorcion y procedimiento para su obtencion.
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US6139865A (en) * 1996-10-01 2000-10-31 Eurand America, Inc. Taste-masked microcapsule compositions and methods of manufacture
DE19724696A1 (de) * 1997-06-12 1998-12-24 Hexal Ag Pharmazeutische Zubereitung mit drei Pelletarten
US6419960B1 (en) 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US6673367B1 (en) 1998-12-17 2004-01-06 Euro-Celtique, S.A. Controlled/modified release oral methylphenidate formulations
US7083808B2 (en) 1998-12-17 2006-08-01 Euro-Celtique S.A. Controlled/modified release oral methylphenidate formulations
EP1146862B1 (de) 1999-01-29 2003-04-23 Disphar International B.V. Pharmazeutische zusammensetzungen
GB0007419D0 (en) † 2000-03-27 2000-05-17 Smithkline Beecham Gmbh Composition
WO2001076557A1 (fr) * 2000-04-10 2001-10-18 Sumitomo Pharmaceuticals Co., Ltd. Preparations a liberation prolongee
US6500454B1 (en) 2001-10-04 2002-12-31 Eurand Pharmaceuticals Ltd. Timed, sustained release systems for propranolol
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US6663888B2 (en) 2001-12-14 2003-12-16 Eurand Pharmaceuticals Ltd. Pulsatile release histamine H2 antagonist dosage form
ATE407674T1 (de) 2002-04-09 2008-09-15 Flamel Tech Sa Orale pharmazeutische formulierung in form einer wässrigen suspension von mikrokapseln zur modifizierten freisetzung von amoxicillin
ATE419840T1 (de) 2002-04-09 2009-01-15 Flamel Tech Sa Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
AU2003269741A1 (en) * 2002-05-15 2003-12-02 Sun Pharmaceutical Industries Limited Coated sustained release tablets of a hygroscopic compound for once-a-day therapy
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
DE10315538A1 (de) * 2003-04-04 2004-10-21 Siemens Ag Teilchen mit einer Membran
JP2007517908A (ja) * 2004-01-16 2007-07-05 グラクソ　グループ　リミテッド 腸溶性ポリマー中における脂質基材の処方のカプセル封入
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
ES2409347T3 (es) 2004-10-21 2013-06-26 Aptalis Pharmatech, Inc. Composiciones farmacéuticas de sabor enmascarado con agentes porogénicos gastrosolubles
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
EP1726301A1 (de) * 2005-05-24 2006-11-29 Flamel Technologies Pharmazeutische Zusammensetzung zur Behandlung COX-2 vermittelter Krankheiten
EP1726300A1 (de) * 2005-05-24 2006-11-29 Flamel Technologies Orale pharmazeutische Formulierung zur Vorbeugung und/oder Behandlung kardiovaskulärer und inflammatorischer Erkrankungen
ATE480229T1 (de) * 2005-05-24 2010-09-15 Flamel Tech Sa Orale pharmazeutische zusammensetzung zur behandlung einer cox-2-vermittelten erkrankung
US20080199516A1 (en) * 2005-07-26 2008-08-21 Glaxo Group Limited Encapsulation Of Lipid-Based Formulations In Enteric Polymers
GB0707489D0 (en) * 2007-04-18 2007-05-23 Renaissance Pharma Compounds
CN101229141B (zh) * 2008-02-29 2010-07-07 常州制药厂有限公司 一种阿司匹林缓释片及其制备方法
MX2012006240A (es) 2009-12-02 2012-10-03 Aptalis Pharma Ltd Microcapsulas de fexofenadina y composiciones que contienen las mismas.
US8397733B2 (en) * 2010-01-15 2013-03-19 Celanese Acetate Llc Degradable cigarette filter: pill with multilayered coating
US8327856B2 (en) * 2010-03-30 2012-12-11 Celanese Acetate Llc Environmentally degradable cigarette filter
CA2902911C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2224256C2 (de) * 1972-05-18 1985-05-23 Sanol-Arzneimittel Dr. Schwarz Gmbh, 4019 Monheim Arzneimittelzubereitung
FR2287216A1 (fr) * 1974-10-09 1976-05-07 Narcisse Guy Nouvelle forme galenique d'administration de medicaments et medicaments prepares sous cette nouvelle forme
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
JPS5916821A (ja) * 1982-07-16 1984-01-28 Tanabe Seiyaku Co Ltd 非凝集性マイクロカプセルの製法
JPS601128A (ja) * 1983-06-15 1985-01-07 Shionogi & Co Ltd 作用持続型セフアクロル製剤
EP0130162B1 (de) * 1983-06-22 1987-09-09 The Ohio State University Research Foundation Herstellung eines feinteiligen Materials und Verkapselung
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning

Also Published As

Publication number Publication date
DK153787D0 (da) 1987-03-26
NO871243D0 (no) 1987-03-25
AU591248B2 (en) 1989-11-30
NO175286B (no) 1994-06-20
JPH08175978A (ja) 1996-07-09
JPS62246513A (ja) 1987-10-27
NO871243L (no) 1987-09-28
DK153787A (da) 1987-09-28
CA1285482C (en) 1991-07-02
AU7012487A (en) 1987-10-01
DE3782840T2 (de) 1993-04-01
JP2653996B2 (ja) 1997-09-17
JP2657057B2 (ja) 1997-09-24
NO175286C (no) 1994-09-28
EP0239361A1 (de) 1987-09-30
EP0239361B1 (de) 1992-12-02

Similar Documents

Publication Publication Date Title
DE3782840D1 (de) Arzneimittel mit verzoegerter freigabe.
DE69003568D1 (de) Arzneimittel mit verzoegerter freigabe.
DE3684446D1 (de) Arzneimittel mit verzoegerter stossweiser freisetzung.
DE3780223D1 (de) Arzneimittel mit gesteuerter freisetzung.
DE3686275D1 (de) Praeparate mit verzoegerter freisetzung.
DE3778106D1 (de) Dosierungsform mit verzoegernder freisetzung.
DE3775483D1 (de) Zubereitung mit verzoegerter freigabe.
DE69018647D1 (de) Arzneimittel.
DE69004214D1 (de) Arzneimittel mit verzögerter freisetzung und ph-gesteuerten membranüberzügen.
DE3786481D1 (de) Topische antimikrobielle arzneimittel.
DE3676248D1 (de) Ubidecarenon enthaltende arzneimittel.
NO903001D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater med forlenget frigivelse.
NO892588L (no) Pulverpreparater.
DE3880593D1 (de) Arzneizubereitungen mit retardierter wirkstofffreisetzung.
ATE92309T1 (de) Matrix-zubereitungen mit verzoegerter freisetzung.
DE68917544D1 (de) Durchsichtiges Präparat.
DE68908354D1 (de) Verpackung fuer arzneimittel.
NO872933L (no) SanitŸrprodukter.
DE3280287D1 (de) Arzneimittel mit antikrebs-wirkung.
DE3782439D1 (de) Dihydropyridin-formulierung mit verzoegerter freigabe.
DE3861529D1 (de) Arzneizubereitung mit indomethacin.
FI874382A (fi) Farmaceutiska preparat.
FI905236A0 (fi) Deoxiribonukleosider innehaollande farmaceutiska konsistenser foer laekning av saor.
DE3763519D1 (de) Heilnahrungsmittel.
DE68907392D1 (de) Dysmnesie modifizierende arzneimittel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee